Structure-Function Analysis of DipA, a Francisella tularensis Virulence Factor Required for Intracellular Replication

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Chong, Audrey ^a   Child, Robert ^a   Wehrly, Tara D ^a   Rockx Brouwer, Dedeke ^a,d   Qin, Aiping ^b   Mann, Barbara J ^b,c   Celli, Jean ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; MUTANT PROTEIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN FOPA; PROTEIN DIPA; UNCLASSIFIED DRUG; VIRULENCE FACTOR; FOPA PROTEIN, FRANCISELLA TULARENSIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOCHEMISTRY; CELL MEMBRANE; CONTROLLED STUDY; FRANCISELLA TULARENSIS; GENE DELETION; HOST PATHOGEN INTERACTION; IMMUNOPRECIPITATION; MACROPHAGE; MOUSE; MUTAGENESIS; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; TULAREMIA; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CHEMISTRY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PATHOLOGY;

BACTERIA (MICROORGANISMS); FRANCISELLA; FRANCISELLA TULARENSIS; FRANCISELLA TULARENSIS SUBSP. TULARENSIS; MUS;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CELLS, CULTURED; FRANCISELLA TULARENSIS; MACROPHAGES; MICE; MICE, INBRED BALB C; STRUCTURE-ACTIVITY RELATIONSHIP; TULAREMIA; VIRULENCE FACTORS;

EID: 84879497532     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067965     Document Type: Article

References (87)

1. Pechous RD, McCarthy TR, Zahrt TC, (2009) Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development. Microbiol Mol Biol Rev 73: 684-711. doi:10.1128/MMBR.00028-09. PubMed: 19946137.
2. Oyston PC, Sjostedt A, Titball RW, (2004) Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol 2: 967-978. doi:10.1038/nrmicro1045. PubMed: 15550942.
3. Keim P, Johansson A, Wagner DM, (2007) Molecular epidemiology, evolution, and ecology of Francisella. Ann N Y Acad Sci 1105: 30-66. doi:10.1196/annals.1409.011. PubMed: 17435120.
4. Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, et al. (2008) Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect Immun 76: 5843-5852. doi:10.1128/IAI.01176-08. PubMed: 18852251.
5. Anthony LD, Burke RD, Nano FE, (1991) Growth of Francisella spp. in rodent macrophages. Infect Immun 59: 3291-3296. PubMed: 1879943.
6. Forestal CA, Benach JL, Carbonara C, Italo JK, Lisinski TJ, et al. (2003) Francisella tularensis selectively induces proinflammatory changes in endothelial cells. J Immunol 171: 2563-2570. PubMed: 12928407.
7. Balagopal A, MacFarlane AS, Mohapatra N, Soni S, Gunn JS, et al. (2006) Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages. Infect Immun 74: 5114-5125. doi:10.1128/IAI.00795-06. PubMed: 16926403.
8. Fortier AH, Green SJ, Polsinelli T, Jones TR, Crawford RM, et al. (1994) Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. Immunol Ser 60: 349-361. PubMed: 8251580.
9. Chong A, Wehrly TD, Nair V, Fischer ER, Barker JR, et al. (2008) The early phagosomal stage of Francisella tularensis determines optimal phagosomal escape and Francisella pathogenicity island protein expression. Infect Immun 76: 5488-5499. doi:10.1128/IAI.00682-08. PubMed: 18852245.
10. Wehrly TD, Chong A, Virtaneva K, Sturdevant DE, Child R, et al. (2009) Intracellular biology and virulence determinants of Francisella tularensis revealed by transcriptional profiling inside macrophages. Cell Microbiol 11: 1128-1150. doi:10.1111/j.1462-5822.2009.01316.x. PubMed: 19388904.
11. Checroun C, Wehrly TD, Fischer ER, Hayes SF, Celli J, (2006) Autophagy-mediated reentry of Francisella tularensis into the endocytic compartment after cytoplasmic replication. Proc Natl Acad Sci U S A 103: 14578-14583. doi:10.1073/pnas.0601838103. PubMed: 16983090.
12. Clemens DL, Lee BY, Horwitz MA, (2009) Francisella tularensis phagosomal escape does not require acidification of the phagosome. Infect Immun 77: 1757-1773. doi:10.1128/IAI.01485-08. PubMed: 19237528.
13. Clemens DL, Lee BY, Horwitz MA, (2004) Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Infect Immun 72: 3204-3217. doi:10.1128/IAI.72.6.3204-3217.2004. PubMed: 15155622.
14. Santic M, Molmeret M, Abu Kwaik Y, (2005) Modulation of biogenesis of the Francisella tularensis subsp. novicida-containing phagosome in quiescent human macrophages and its maturation into a phagolysosome upon activation by IFN-gamma. Cell Microbiol 7: 957-967. doi:10.1111/j.1462-5822.2005.00529.x. PubMed: 15953028.
15. Golovliov I, Baranov V, Krocova Z, Kovarova H, Sjöstedt A, (2003) An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Infect Immun 71: 5940-5950. doi:10.1128/IAI.71.10.5940-5950.2003. PubMed: 14500514.
16. Lai XH, Golovliov I, Sjöstedt A, (2001) Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication. Infect Immun 69: 4691-4694. doi:10.1128/IAI.69.7.4691-4694.2001. PubMed: 11402018.
17. Lai XH, Sjöstedt A, (2003) Delineation of the molecular mechanisms of Francisella tularensis-induced apoptosis in murine macrophages. Infect Immun 71: 4642-4646. doi:10.1128/IAI.71.8.4642-4646.2003. PubMed: 12874344.
18. Santic M, Pavokovic G, Jones S, Asare R, Kwaik YA, (2010) Regulation of apoptosis and anti-apoptosis signalling by Francisella tularensis. Microbes Infect 12: 126-134. doi:10.1016/j.micinf.2009.11.003. PubMed: 19925880.
19. Mariathasan S, Weiss DS, Dixit VM, Monack DM, (2005) Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J Exp Med 202: 1043-1049. doi:10.1084/jem.20050977. PubMed: 16230474.
20. Chong A, Celli J, (2010) The Francisella intracellular life cycle: toward molecular mechanisms of intracellular survival and proliferation. Front Microbiol 1: 138. PubMed: 21687806.
21. Meibom KL, Charbit A, (2010) The unraveling panoply of Francisella tularensis virulence attributes. Curr Opin Microbiol 13: 11-17. doi:10.1016/j.mib.2009.11.007. PubMed: 20034843.
22. Nano FE, Zhang N, Cowley SC, Klose KE, Cheung KK, et al. (2004) A Francisella tularensis pathogenicity island required for intramacrophage growth. J Bacteriol 186: 6430-6436. doi:10.1128/JB.186.19.6430-6436.2004. PubMed: 15375123.
23. Gray CG, Cowley SC, Cheung KK, Nano FE, (2002) The identification of five genetic loci of Francisella novicida associated with intracellular growth. FEMS Microbiol Lett 215: 53-56. doi:10.1111/j.1574-6968.2002.tb11369.x. PubMed: 12393200.
24. Brotcke A, Weiss DS, Kim CC, Chain P, Malfatti S, et al. (2006) Identification of MglA-regulated genes reveals novel virulence factors in Francisella tularensis. Infect Immun 74: 6642-6655. doi:10.1128/IAI.01250-06. PubMed: 17000729.
25. Weiss DS, Brotcke A, Henry T, Margolis JJ, Chan K, et al. (2007) In vivo negative selection screen identifies genes required for Francisella virulence. Proc Natl Acad Sci U S A 104: 6037-6042. doi:10.1073/pnas.0609675104. PubMed: 17389372.
26. Lindgren H, Golovliov I, Baranov V, Ernst RK, Telepnev M, et al. (2004) Factors affecting the escape of Francisella tularensis from the phagolysosome. J Med Microbiol 53: 953-958. doi:10.1099/jmm.0.45685-0. PubMed: 15358816.
27. Twine S, Byström M, Chen W, Forsman M, Golovliov I, et al. (2005) A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect Immun 73: 8345-8352. doi:10.1128/IAI.73.12.8345-8352.2005. PubMed: 16299332.
28. Fuller JR, Craven RR, Hall JD, Kijek TM, Taft-Benz S, et al. (2008) RipA, a cytoplasmic membrane protein conserved among Francisella species, is required for intracellular survival. Infect Immun 76: 4934-4943. doi:10.1128/IAI.00475-08. PubMed: 18765722.
29. Qin A, Mann BJ, (2006) Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2. BMC Microbiol 6: 69. doi:10.1186/1471-2180-6-69. PubMed: 16879747.
30. Qin A, Scott DW, Thompson JA, Mann BJ, (2009) Identification of an essential Francisella tularensis subsp. tularensis virulence factor. Infect Immun 77: 152-161. doi:10.1128/IAI.01113-08. PubMed: 18981253.
31. Qin A, Scott DW, Rabideau MM, Moore EA, Mann BJ, (2011) Requirement of the CXXC motif of novel Francisella infectivity potentiator protein B FipB, and FipA in virulence of F. tularensis subsp. tularensis. PLOS ONE 6: e24611. doi:10.1371/journal.pone.0024611. PubMed: 21931773.
32. Nano FE, (1988) Identification of a heat-modifiable protein of Francisella tularensis and molecular cloning of the encoding gene. Microb Pathog 5: 109-119. doi:10.1016/0882-4010(88)90013-7. PubMed: 3237052.
33. Huntley JF, Conley PG, Hagman KE, Norgard MV, (2007) Characterization of Francisella tularensis outer membrane proteins. J Bacteriol 189: 561-574. doi:10.1128/JB.01505-06. PubMed: 17114266.
34. Schmerk CL, Duplantis BN, Wang D, Burke RD, Chou AY, et al. (2009) Characterization of the pathogenicity island protein PdpA and its role in the virulence of Francisella novicida. Microbiology 155: 1489-1497. doi:10.1099/mic.0.025379-0. PubMed: 19372153.
35. Bröms JE, Lavander M, Meyer L, Sjöstedt A, (2011) IglG and IglI of the Francisella pathogenicity island are important virulence determinants of Francisella tularensis LVS. Infect Immun 79: 3683-3696. doi:10.1128/IAI.01344-10. PubMed: 21690239.
36. de Bruin OM, Duplantis BN, Ludu JS, Hare RF, Nix EB, et al. (2011) The biochemical properties of the Francisella pathogenicity island (FPI)-encoded proteins IglA, IglB, IglC, PdpB and DotU suggest roles in type VI secretion. Microbiology 157: 3483-3491. doi:10.1099/mic.0.052308-0. PubMed: 21980115.
37. de Bruin OM, Ludu JS, Nano FE, (2007) The Francisella pathogenicity island protein IglA localizes to the bacterial cytoplasm and is needed for intracellular growth. BMC Microbiol 7: 1. doi:10.1186/1471-2180-7-1. PubMed: 17233889.
38. Ludu JS, de Bruin OM, Duplantis BN, Schmerk CL, Chou AY, et al. (2008) The Francisella pathogenicity island protein PdpD is required for full virulence and associates with homologues of the type VI secretion system. J Bacteriol 190: 4584-4595. doi:10.1128/JB.00198-08. PubMed: 18469101.
39. Melillo A, Sledjeski DD, Lipski S, Wooten RM, Basrur V, et al. (2006) Identification of a Francisella tularensis LVS outer membrane protein that confers adherence to A549 human lung cells. FEMS Microbiol Lett 263: 102-108. doi:10.1111/j.1574-6968.2006.00413.x. PubMed: 16958857.
40. Barker JR, Chong A, Wehrly TD, Yu JJ, Rodriguez SA, et al. (2009) The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence. Mol Microbiol 74: 1459-1470. doi:10.1111/j.1365-2958.2009.06947.x. PubMed: 20054881.
41. Larsson P, Oyston PC, Chain P, Chu MC, Duffield M, et al. (2005) The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat Genet 37: 153-159. doi:10.1038/ng1499. PubMed: 15640799.
42. Bröms JE, Meyer L, Sun K, Lavander M, Sjöstedt A, (2012) Unique substrates secreted by the type VI secretion system of Francisella tularensis during intramacrophage infection. PLOS ONE 7: e50473. doi:10.1371/journal.pone.0050473. PubMed: 23185631.
43. Mittl PR, Schneider-Brachert W, (2007) Sel1-like repeat proteins in signal transduction. Cell Signal 19: 20-31. doi:10.1016/j.cellsig.2006.05.034. PubMed: 16870393.
44. Roy A, Kucukural A, Zhang Y, (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5: 725-738. doi:10.1038/nprot.2010.5. PubMed: 20360767.
45. Lupas AN, Gruber M, (2005) The structure of alpha-helical coiled coils. Adv Protein Chem 70: 37-78. doi:10.1016/S0065-3233(05)70003-6. PubMed: 15837513.
46. Fulop M, Manchee R, Titball R, (1996) Role of two outer membrane antigens in the induction of protective immunity against Francisella tularensis strains of different virulence. FEMS Immunol Med Microbiol 13: 245-247. doi:10.1111/j.1574-695X.1996.tb00245.x. PubMed: 8861037.
47. Blau K, Portnoi M, Shagan M, Kaganovich A, Rom S, et al. (2007) Flamingo cadherin: a putative host receptor for Streptococcus pneumoniae. J Infect Dis 195: 1828-1837. doi:10.1086/518038. PubMed: 17492599.
48. Tunio SA, Oldfield NJ, Berry A, Ala'Aldeen DA, Wooldridge KG, et al. (2010) The moonlighting protein fructose-1, 6-bisphosphate aldolase of Neisseria meningitidis: surface localization and role in host cell adhesion. Mol Microbiol 76: 605-615. doi:10.1111/j.1365-2958.2010.07098.x. PubMed: 20199602.
49. de la Paz Santangelo M, Gest PM, Guerin ME, Coinçon M, Pham H, et al. (2011) Glycolytic and non-glycolytic functions of Mycobacterium tuberculosis fructose-1,6-bisphosphate aldolase, an essential enzyme produced by replicating and non-replicating bacilli. J Biol Chem 286: 40219-40231. doi:10.1074/jbc.M111.259440. PubMed: 21949126.
50. Ling E, Feldman G, Portnoi M, Dagan R, Overweg K, et al. (2004) Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin Exp Immunol 138: 290-298. doi:10.1111/j.1365-2249.2004.02628.x. PubMed: 15498039.
51. Agarwal S, Kulshreshtha P, Bambah Mukku D, Bhatnagar R, (2008) alpha-Enolase binds to human plasminogen on the surface of Bacillus anthracis. Biochim Biophys Acta 1784: 986-994. doi:10.1016/j.bbapap.2008.03.017. PubMed: 18456007.
52. Gallagher LA, Ramage E, Jacobs MA, Kaul R, Brittnacher M, et al. (2007) A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate. Proc Natl Acad Sci U S A 104: 1009-1014. doi:10.1073/pnas.0606713104. PubMed: 17215359.
53. Chong A, Wehrly TD, Child R, Hansen B, Hwang S, et al. (2012) Cytosolic clearance of replication-deficient mutants reveals Francisella tularensis interactions with the autophagic pathway. Autophagy 80--1.
54. Bönquist L, Lindgren H, Golovliov I, Guina T, Sjöstedt A, (2008) MglA and Igl proteins contribute to the modulation of Francisella tularensis live vaccine strain-containing phagosomes in murine macrophages. Infect Immun 76: 3502-3510. doi:10.1128/IAI.00226-08. PubMed: 18474647.
55. Santic M, Molmeret M, Klose KE, Jones S, Kwaik YA, (2005) The Francisella tularensis pathogenicity island protein IglC and its regulator MglA are essential for modulating phagosome biogenesis and subsequent bacterial escape into the cytoplasm. Cell Microbiol 7: 969-979. doi:10.1111/j.1462-5822.2005.00526.x. PubMed: 15953029.
56. Schmerk CL, Duplantis BN, Howard PL, Nano FE, (2009) A Francisella novicida pdpA mutant exhibits limited intracellular replication and remains associated with the lysosomal marker LAMP-1. Microbiology 155: 1498-1504. doi:10.1099/mic.0.025445-0. PubMed: 19372155.
57. Rockx-Brouwer D, Chong A, Wehrly TD, Child R, Crane DD, et al. (2012) Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination. PLOS ONE 7: e37752. doi:10.1371/journal.pone.0037752. PubMed: 22662210.
58. Travers KJ, Patil CK, Wodicka L, Lockhart DJ, Weissman JS, et al. (2000) Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 101: 249-258. doi:10.1016/S0092-8674(00)80835-1. PubMed: 10847680.
59. Okabe M, Yakushi T, Homma M, (2005) Interactions of MotX with MotY and with the PomA/PomB sodium ion channel complex of the Vibrio alginolyticus polar flagellum. J Biol Chem 280: 25659-25664. doi:10.1074/jbc.M500263200. PubMed: 15866878.
60. McCarter LL, (1994) MotX, the channel component of the sodium-type flagellar motor. J Bacteriol 176: 5988-5998. PubMed: 7928960.
61. Conover GM, Derré I, Vogel JP, Isberg RR, (2003) The Legionella pneumophila LidA protein: a translocated substrate of the Dot/Icm system associated with maintenance of bacterial integrity. Mol Microbiol 48: 305-321. doi:10.1046/j.1365-2958.2003.03400.x. PubMed: 12675793.
62. Cirillo SL, Lum J, Cirillo JD, (2000) Identification of novel loci involved in entry by Legionella pneumophila. Microbiology 146(6):: 1345-1359. PubMed: 10846213.
63. Newton HJ, Sansom FM, Dao J, McAlister AD, Sloan J, et al. (2007) Sel1 repeat protein LpnE is a Legionella pneumophila virulence determinant that influences vacuolar trafficking. Infect Immun 75: 5575-5585. doi:10.1128/IAI.00443-07. PubMed: 17893138.
64. Engel J, Kammerer RA, (2000) What are oligomerization domains good for? Matrix Biol 19: 283-288. doi:10.1016/S0945-053X(00)00075-5. PubMed: 10963988.
65. Uversky VN, Gillespie JR, Fink AL, (2000) Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins 41: 415-427. doi:10.1002/1097-0134(20001115)41:3. PubMed: 11025552.
66. Newman JR, Wolf E, Kim PS, (2000) A computationally directed screen identifying interacting coiled coils from Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 97: 13203-13208. doi:10.1073/pnas.97.24.13203. PubMed: 11087867.
67. Gazi AD, Charova SN, Panopoulos NJ, Kokkinidis M, (2009) Coiled-coils in type III secretion systems: structural flexibility, disorder and biological implications. Cell Microbiol 11: 719-729. doi:10.1111/j.1462-5822.2009.01297.x. PubMed: 19215225.
68. Delahay RM, Knutton S, Shaw RK, Hartland EL, Pallen MJ, et al. (1999) The coiled-coil domain of EspA is essential for the assembly of the type III secretion translocon on the surface of enteropathogenic Escherichia coli. J Biol Chem 274: 35969-35974. doi:10.1074/jbc.274.50.35969. PubMed: 10585486.
69. Knodler LA, Ibarra JA, Pérez-Rueda E, Yip CK, Steele-Mortimer O, (2011) Coiled-coil domains enhance the membrane association of Salmonella type III effectors. Cell Microbiol 13: 1497-1517. doi:10.1111/j.1462-5822.2011.01635.x. PubMed: 21679290.
70. Sukumaran SK, Shimada H, Prasadarao NV, (2003) Entry and intracellular replication of Escherichia coli K1 in macrophages require expression of outer membrane protein A. Infect Immun 71: 5951-5961. doi:10.1128/IAI.71.10.5951-5961.2003. PubMed: 14500515.
71. Dabo SM, Confer A, Montelongo M, York P, Wyckoff JH 3rd, (2008) Vaccination with Pasteurella multocida recombinant OmpA induces strong but non-protective and deleterious Th2-type immune response in mice. Vaccine 26: 4345-4351. doi:10.1016/j.vaccine.2008.06.029. PubMed: 18598730.
72. Kim SW, Choi CH, Moon DC, Jin JS, Lee JH, et al. (2009) Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. FEMS Microbiol Lett 301: 224-231. doi:10.1111/j.1574-6968.2009.01820.x. PubMed: 19878322.
73. Torres AG, Kaper JB, (2003) Multiple elements controlling adherence of enterohemorrhagic Escherichia coli O157:H7 to HeLa cells. Infect Immun 71: 4985-4995. doi:10.1128/IAI.71.9.4985-4995.2003. PubMed: 12933841.
74. Fito-Boncompte L, Chapalain A, Bouffartigues E, Chaker H, Lesouhaitier O, et al. (2011) Full virulence of Pseudomonas aeruginosa requires OprF. Infect Immun 79: 1176-1186. doi:10.1128/IAI.00850-10. PubMed: 21189321.
75. Nicholson TF, Watts KM, Hunstad DA, (2009) OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis. Infect Immun 77: 5245-5251. doi:10.1128/IAI.00670-09. PubMed: 19797074.
76. Serino L, Nesta B, Leuzzi R, Fontana MR, Monaci E, et al. (2007) Identification of a new OmpA-like protein in Neisseria gonorrhoeae involved in the binding to human epithelial cells and in vivo colonization. Mol Microbiol 64: 1391-1403. doi:10.1111/j.1365-2958.2007.05745.x. PubMed: 17542928.
77. Bartra SS, Gong X, Lorica CD, Jain C, Nair MK, et al. (2012) The outer membrane protein A (OmpA) of Yersinia pestis promotes intracellular survival and virulence in mice. Microb Pathog 52: 41-46. doi:10.1016/j.micpath.2011.09.009. PubMed: 22023991.
78. Wang Y, (2002) The function of OmpA in Escherichia coli. Biochem Biophys Res Commun 292: 396-401. doi:10.1006/bbrc.2002.6657. PubMed: 11906175.
79. Sonntag I, Schwarz H, Hirota Y, Henning U, (1978) Cell envelope and shape of Escherichia coli: multiple mutants missing the outer membrane lipoprotein and other major outer membrane proteins. J Bacteriol 136: 280-285. PubMed: 361695.
80. Sugawara E, Nikaido H, (2012) OmpA is the principal nonspecific slow porin of Acinetobacter baumannii. J Bacteriol 194: 4089-4096. doi:10.1128/JB.00435-12. PubMed: 22636785.
81. Nestorovich EM, Sugawara E, Nikaido H, Bezrukov SM, (2006) Pseudomonas aeruginosa porin OprF: properties of the channel. J Biol Chem 281: 16230-16237. doi:10.1074/jbc.M600650200. PubMed: 16617058.
82. Lupas A, (1996) Prediction and analysis of coiled-coil structures. Methods Enzymol 266: 513-525. doi:10.1016/S0076-6879(96)66032-7. PubMed: 8743703.
83. Delorenzi M, Speed T, (2002) An HMM model for coiled-coil domains and a comparison with PSSM-based predictions. Bioinformatics 18: 617-625. doi:10.1093/bioinformatics/18.4.617. PubMed: 12016059.
84. Zhang Y, (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9: 40. doi:10.1186/1471-2105-9-40. PubMed: 18215316.
85. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612. doi:10.1002/jcc.20084. PubMed: 15264254.
86. Maier TM, Havig A, Casey M, Nano FE, Frank DW, et al. (2004) Construction and characterization of a highly efficient Francisella shuttle plasmid. Appl Environ Microbiol 70: 7511-7519. doi:10.1128/AEM.70.12.7511-7519.2004. PubMed: 15574954.
87. Charpentier X, Oswald E, (2004) Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter. J Bacteriol 186: 5486-5495. doi:10.1128/JB.186.16.5486-5495.2004. PubMed: 15292151.